Episode 295: ASCO GU 2024 - Adjuvant Therapy in Renal Cancer

Pedro Barata, MD, MSc, FACP, gives an overview of the CheckMate 914 trial on nivolumab plus ipilimumab for the adjuvant treatment of localized renal cell carcinoma at ASCO GU 2024.
Dr. Barata is a genitourinary oncologist at University Hospitals Seidman Cancer Center.